Condition

Fetal Growth Retardation

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 26 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials26
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

26 shown
PROTECT-Africa: Biomarker Validation for Preeclampsia TriageNCT07810439 · 2026-02-05
RECRUITING
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental DopplerNCT05284474 · 2024-06-03
NOT_YET_RECRUITING
Optimization of Cervical Collections in PregnancyNCT06323187 · 2024-05-01
NOT_YET_RECRUITING
Pregnancy RepositoryNCT06339606 · 2024-05-01
NOT_YET_RECRUITING
A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in UltrasoundNCT06268392 · 2024-02-15
UNKNOWN
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal OutcomesNCT06416995 · 2023-03-03
UNKNOWN
LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)NCT04762992 · 2022-07-18
ENROLLING_BY_INVITATION
Study of Pregnancy Pathologies Associated With Placental AbnormalitiesNCT05188066 · 2022-01-06
NOT_YET_RECRUITING
Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)NCT05123677 · 2022-01-01
UNKNOWN
The START Clinic: a Feasibility StudyNCT04488861 · 2021-03-15
UNKNOWN
Bioimpedence and Arterial Function Monitoring at Birth and in InfantsNCT04720690 · 2020-12-01
UNKNOWN
Dilapan-S®: A Multicenter US E-registryNCT04451109 · 2020-12-01
ACTIVE_NOT_RECRUITING
Active Pregnancy Against COVID-19NCT04563065 · 2020-08-01
UNKNOWN
Vitamin D in PregnancyNCT04291313 · 2020-06-08
UNKNOWN
MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivoNCT04389099 · 2019-11-18
COMPLETED
Fetal Autonomic Nervous sysTem EvaluationNCT06330987 · 2019-08-13
UNKNOWN
Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb VolumeNCT03002246 · 2017-01-06
COMPLETED
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersNCT02336243 · 2015-05-01
UNKNOWN
Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.NCT02280031 · 2014-11-01
COMPLETED
Trial of Early Screening Test for Pre-eclampsia and Growth RestrictionNCT03674606 · 2014-02-01
COMPLETED
Obesity and Oral Contraceptive FailureNCT01944306 · 2013-08-01
TERMINATED
Progesterone for First Trimester Vaginal BleedingNCT01501890 · 2012-01-01
WITHDRAWN
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of PreeclampsiaNCT01352234 · 2011-09-01
COMPLETED
The Role of Pro-angiogenic Immune Cells in Human PregnanciesNCT01177020 · 2010-08-01
UNKNOWN
Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth RestrictionNCT00197340 · 2003-08-01
COMPLETED
Doppler and Biological Second Trimester Placental Insufficiency ScreeningNCT00465634 · 2003-05-01
COMPLETED

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Leading sponsors

Trial status mix

UNKNOWN10
COMPLETED7
NOT_YET_RECRUITING4
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
RECRUITING1
TERMINATED1
WITHDRAWN1

Phase mix

NA4
PHASE33
PHASE42
PHASE21
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.